National Institute for Medical Research, Muhimbili Medical Research Centre, Dar es Salaam, Tanzania.
BMC Infect Dis. 2010 Jul 16;10:210. doi: 10.1186/1471-2334-10-210.
Tanzania ranks 15th among the world's 22 countries with the largest tuberculosis burden and tuberculosis has continued to be among the major public health problems in the country. Limited data, especially in patients co infected with HIV, are available to predict the duration of time required for a smear positive pulmonary tuberculosis patient to achieve sputum conversion after starting effective treatment. In this study we assessed the sputum smear and culture conversion rates among HIV positive and HIV negative smear positive pulmonary tuberculosis patients in Dar es Salaam
The study was a prospective cohort study which lasted for nine months, from April to December 2008
A total of 502 smear positive pulmonary tuberculosis patients were recruited. HIV test results were obtained for 498 patients, of which 33.7% were HIV positive. After two weeks of treatment the conversion rate by standard sputum microscopy was higher in HIV positive(72.8%) than HIV negative(63.3%) patients by univariate analysis(P = 0.046), but not in multivariate analysis. Also after two weeks of treatment the conversion rate by fluorescence microscopy was higher in HIV positive (72.8%) than in HIV negative(63.2%) patients by univariate analysis (P = 0.043) but not in the multivariate analysis. The conversion rates by both methods during the rest of the treatment period (8, 12, and 20 weeks) were not significantly different between HIV positive and HIV negative patients.With regards to culture, the conversion rate during the whole period of the treatment (2, 8, 12 and 20 weeks) were not significantly different between HIV positive and HIV negative patients.
Conversion rates of standard smear microscopy, fluorescence microscopy and culture did not differ between HIV positive and HIV negative pulmonary tuberculosis patients.
坦桑尼亚在全球 22 个结核病负担最重的国家中排名第 15 位,结核病一直是该国的主要公共卫生问题之一。由于数据有限,特别是在合并感染 HIV 的患者中,目前尚无法预测涂片阳性肺结核患者在开始有效治疗后实现痰菌阴转所需的时间。在这项研究中,我们评估了达累斯萨拉姆的 HIV 阳性和 HIV 阴性涂片阳性肺结核患者的痰涂片和培养转换率。
这项研究是一项前瞻性队列研究,从 2008 年 4 月至 12 月持续了 9 个月。
共招募了 502 例涂片阳性肺结核患者。对 498 例患者进行了 HIV 检测,其中 33.7%为 HIV 阳性。在治疗两周后,单变量分析显示,HIV 阳性患者(72.8%)的标准痰镜检转化率高于 HIV 阴性患者(63.3%)(P=0.046),但多变量分析结果并非如此。同样,在治疗两周后,HIV 阳性患者(72.8%)的荧光显微镜检查转化率高于 HIV 阴性患者(63.2%)(P=0.043),但多变量分析结果并非如此。在治疗的其余时间(8、12 和 20 周),两种方法的转化率在 HIV 阳性和 HIV 阴性患者之间均无显著差异。在培养方面,治疗期间(2、8、12 和 20 周)的转化率在 HIV 阳性和 HIV 阴性患者之间也没有显著差异。
HIV 阳性和 HIV 阴性肺结核患者的标准涂片显微镜检查、荧光显微镜检查和培养的转化率没有差异。